Survival of HIV-1 in syringes: Effects of temperature during storage

Substance Use and Misuse

Volumn 35, Issue 10, 2000, Pages 1369-1383

  Abdala, Nadia ^a   Reyes, Rina ^b   Carney, John M ^a   Heimer, Robert ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b AMHERST COLLEGE   (United States)

Author keywords

HIV 1 culture; HIV 1 transmission; Injection drug use; Syringes

Indexed keywords

ARTICLE; BLOOD STORAGE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; NEEDLE; PRIORITY JOURNAL; SYRINGE; TEMPERATURE SENSITIVITY; VIROGENESIS; VIRUS INFECTIVITY; VIRUS TRANSMISSION;

EID: 0033931228     PISSN: 10826084     EISSN: None     Source Type: Journal    
DOI: 10.3109/10826080009148220     Document Type: Article

References (26)

1. ABDALA, N., STEPHENS, P. C., GRIFFITH, B. P., and HEIMER, R (1999). Survival of HIV-1 in syringes. J. Acquired Immune Deficiency Syndrome Hum. Retroviral. 20: 73-80.
2. AGAR, M. (1973). Ripping and Running. A Formal Ethnography of Urban Heroin Addicts. New York, NY: Seminar Press.
3. BOURGOIS, P. (1998). The moral economics of homeless heroin addicts. Confronting ethnography, HIV risk, and everyday violence in San Francisco shooting encampments. Substance Use Misuse 33: 2323-2351.
4. CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC) (1998). Surveillance Rep. 10(2).
5. CHAISSON, R., BACCHETTI, P., OSMOND, D., BRODIE, B., SANDE, M., and MOSS, A. (1989). Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA 261: 561-565.
6. CHAISSON, R., MOSS, A., ONISHI, R., OSMOND, D., and CARLSON, J. (1987). Human immunodeficiency virus infection in heterosexual intravenous drug users in San Francisco. Am. J. Public Health 77: 169-172.
7. CHITWOOD, D. D., GRIFFIN, D. K., COMERFORD, M., PAGE, J. B., TRAPIDO, E. J., LAI, S., and McCOY, C. B. (1995). Risk factors for HIV-1 seroconversion among drug injectors: A case-control study. Am. J. Public Health 85: 1538-1542.
8. CLATTS, M. C., HEIMER, R., ABDALA, N., SOTHERAN, J. L., GOLDSAMT, L. A., ANDERSON, K. T., GALLO, T. M., HOFFER, L. D., LUCIANO, P. A., and KYRIAKIDES, T. (1999). Illicit drug injection and HIV-1 transmission: Heating drug solutions may inactivate HIV-1. J. Acquired Immune Deficiency Syndrome 22: 194-199.
9. FRIEDMAN, S. R., JOSE, B., DEREN, S., DES JARLAIS, D. C., NEAIGUS, A., and NATIONAL AIDS RESEARCH CONSORTIUM (1995). Risk factors for human immunodeficiency virus seroprevalence cities. Am. J. Epidemiol. 142: 864-874.
10. GAUGHWIN, M. D., GOWANS, E., ALI, R., and BURELL, C. (1991). Bloody needles: The volume of blood transferred in simulations of needlestick injuries and shared use of syringes for injection of intravenous drugs. AIDS 5: 1025-1027.
11. GRUND, J.-P. C. (1993). Drug Use as a Social Ritual: Functionality, Symbolism, and Determinants of Self-Regulation. Rotterdam. The Netherlands: Addiction Research Institute, Erasmus Universitiet.
12. GRUND, J.-P., and STERN, L. S. (1991). Residual blood in syringes: Size and type of syringe are important. AIDS 5: 1532-1533.
13. HOFFMAN, P. N., LARKIN, D. P., and SAMUEL, D. (1989). Needlestick and needleshare -The difference. J. Infect. Dis. 160: 545.
14. HOLLINGER, F. B. (1993). ACTG Virology Manual for HIV Laboratories. Bethesda, MD: Division of AIDS, NIAID, NIH.
15. HOLMBERG, S. D. (1996). The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. Am. J. Public Health 86: 642-654.
16. MARMOR, M., DES JARLAIS, D. C., COHEN, H., FRIEDMAN, S. R., BEATRICE, S. T., DUBIN, N., EL-SADR, W., MILDVAN, D., YANCOVITZ, S., and MATHUR, U. (1987). Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City. AIDS 1: 39-44.
17. MARTIN, L. S., McDOUGAL, and LOSKOSKI, S. L. (1985). Disinfection and inactivation of the human T lymphotropic virus type III/lymphadenopathy-associated virus. J. Infect. Dis. 152: 400-403.
18. MOSS, A. R., VRANIZAN, K., GORTER, R., BACCHETTI, P., WATTERS, J., and OSMOND, D. (1994). HIV seroconversion in intravenous drug users in San Francisco, 1985-1990. AIDS 8: 223-231.
19. MYERS, L. E., McQUAY, L. J., and HOLLINGER, F. B. (1994). Dilution assay statistics. J. Clin. Microbiol. 32: 732-739.
20. NEEDLE, R. H., COYLE, S. L., NORMAND, J., LAMBERT, E., and CESARI, H. (1998). HIV prevention with drug-using populations - Current status and future prospects. Public Health Rep. 113(Suppl. 1): 4-15.
21. SCHOENBAUM, E. E., HARTEL, D., SELWYN, P. A., KLEIN, R. S., DAVENNY, K., ROGERS, M., FEINER, C., and FRIEDLAND, G. (1989). Risk factors for human immunodeficiency virus infection in intravenous drug users. New Engl. J. Med. 321: 874-879.
22. SHAPIRO, M. F., MORTON, S. C., McCAFFREY, D. F., SENTIRFITT, J. W., FLEISHMAN, J. A., PERLMAN, J. F., ATHEY, L. A., KEESEY, J. W., GOLDMAN, D. P., BERRY, S. H., and BOZZETTE, S. A. (1999). Variations in the care of HIV-infected adults in the United States: Results from the HIV Cost and Services Utilization Study. JAMA 281: 2305-2315.
23. STRATHDEE, S. A., PALEPU, A., CORNELISSE, P. G., YIP, B., O'SHAUGHNESSY, M. V., MONTANER, J. S., SCHECHTER, M. T., and HOGG, R. S. (1998). Barriers to use of free antiretroviral therapy in injection drug users. JAMA 280: 547-549.
24. VLAHOV, D., MUNOZ, A., ANTHONY, J. C., COHN, S., CELENTO, D. D., and NELSON, K. E. (1990). Association of drug injection patterns with antibody to human immunodeficiency virus type 1 among intravenous drug users in Baltimore, Maryland. Am. J. Epidemiol. 132: 847-856.
25. WIEBEL, W. W., JIMENEZ, A., JOHNSON, W., OUELLET, L., JEVANOVIC, B. T. L., MURRAY, J., and O'BRIEN, M. U. (1996). Risk behavior and HIV seroincidence among out-of-treatment injection drug users: A four-year prospective study. J. Acquired Immune Deficiency Syndrome Hum. Retroviral. 12: 282-289.
26. ZULE, W. A., and DESMOND, D. P. (1999). An ethnographic comparison of HIV risk behaviors among heroin and methamphetamine injectors. Am. J. Drug Alcohol Abuse 25: 1-12.